Products for Research Use Only

Cabamiquine

CAT: 0804-HY-117684-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-117684-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Cabamiquine (DDD107498) is a potent and orally active antimalarial agent, inhibits multiple life-cycle stages of the parasite, with an EC50 of 1 nM against P. falciparum 3D7. Cabamiquine inhibits protein synthesis by targeting eEF2/CaMKIII, with an EC50 of 2 nM for WT-PfeEF2[1].
CAS Number
1469439-69-7
Product Name Alternative
DDD107498; DDD-498; M5717
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
CaMK; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Neuronal Signaling
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cabamiquine.html
Purity
99.93
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C2=CC=C(C=C2)CN3CCOCC3)=NC4=CC=C(C=C41)F)NCCN5CCCC5
Molecular Formula
C27H31FN4O2
Molecular Weight
462.56
Precautions
H302, H315, H319, H335
References & Citations
[1]Baragaña B, et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015 Jun 18;522 (7556) :315-20.|[2]Baragaña B, et al. Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy. J Med Chem. 2016 Nov 10;59 (21) :9672-9685.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Plasmodium